Characterisation of estrogen receptor alpha (ERα) expression in breast cancer cells and effect of drug treatment using targeted nanoparticles and SERS-Reference-Cited by-同舟云学术

Characterisation of estrogen receptor alpha (ERα) expression in breast cancer cells and effect of drug treatment using targeted nanoparticles and SERS

Published:2020 Issue:22 Volume:145 Page:7225-7233
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Kapara Anastasia¹²³⁴⁵^ORCID,Brunton Valerie G.⁶⁷⁸⁵^ORCID,Graham Duncan¹²³⁴⁵^ORCID,Faulds Karen¹²³⁴⁵^ORCID

Affiliation:

1. Pure and Applied Chemistry

2. Technology and Innovation Centre

3. University of Strathclyde

4. Glasgow

5. UK

6. Edinburgh Cancer Research UK Centre

7. University of Edinburgh

8. Edinburgh

Abstract

Targeted nanoparticles combined with surface enhanced Raman scattering (SERS) are used to characterise the estrogen receptor alpha (ERα) expression levels in breast cancer cells and the effect that SERD drug treatment has on these expression levels.

Funder

Engineering and Physical Sciences Research Council

Medical Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/AN/D0AN01532F

Reference45 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Global Cancer Incidence and Mortality Rates and Trends—An Update